跳转至内容
Merck

02671

Supelco

四氯化碳

analytical standard

别名:

四氯化碳

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
CCl4
CAS号:
分子量:
153.82
Beilstein:
1098295
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

analytical standard

品質等級

蒸汽密度

5.32 (vs air)

蒸汽壓力

143 mmHg ( 30 °C)
91 mmHg ( 20 °C)

化驗

≥99.95% (GC)

儲存期限

limited shelf life, expiry date on the label

技術

HPLC: suitable
gas chromatography (GC): suitable

折射率

n20/D 1.460 (lit.)
n20/D 1.460

bp

76-77 °C (lit.)

mp

−23 °C (lit.)

密度

1.594 g/mL at 25 °C (lit.)

應用

agriculture
cleaning products
cosmetics
environmental
food and beverages
personal care

格式

neat

SMILES 字串

ClC(Cl)(Cl)Cl

InChI

1S/CCl4/c2-1(3,4)5

InChI 密鑰

VZGDMQKNWNREIO-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

Carbon tetrachloride (CCl4) is a clear, colourless, volatile and very stable chlorinated hydrocarbon. It is widely used as a solvent for fats, varnishes, oils, lacquers, resins, and rubber waxes. It is also used as a dry-cleaning agent, as a refrigerant, and as a starting material in the manufacturing of organic compounds.

應用

CCl4 may have been used as reference standard in colorimetric analysis to determine CCl4 in fatty liver sample.

其他說明

可适用销售限制条款

象形圖

Skull and crossbonesHealth hazard

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 3 - Carc. 2 - Ozone 1 - Skin Sens. 1B - STOT RE 1 Inhalation

標靶器官

Liver,Kidney

儲存類別代碼

6.1B - Non-combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Biochemical changes in carbon tetrachloride fatty liver: concentration of carbon tetrachloride in liver and blood.
RECKNAGEL RO, LITTERIA M.
The American Journal of Pathology, 36, 521-531 (1960)
Bruce D. Craig, David S. Anderson
Handbook of Corrosion Data, 257-257 (1994)
Marc Mejias et al.
Gut, 64(4), 657-666 (2014-05-23)
Antiangiogenic strategies have been proposed as a promising new approach for the therapy of portal hypertension and chronic liver disease. Pigment epithelium-derived factor (PEDF) is a powerful endogenous angiogenesis inhibitor whose role in portal hypertension remains unknown. Therefore, we aimed
Samuele De Minicis et al.
Hepatology (Baltimore, Md.), 59(5), 1738-1749 (2013-08-21)
Nonalcoholic fatty liver disease (NAFLD) may lead to hepatic fibrosis. Dietary habits affect gut microbiota composition, whereas endotoxins produced by Gram-negative bacteria stimulate hepatic fibrogenesis. However, the mechanisms of action and the potential effect of microbiota in the liver are
Lutz W D Weber et al.
Critical reviews in toxicology, 33(2), 105-136 (2003-04-24)
The use of many halogenated alkanes such as carbon tetrachloride (CCl4), chloroform (CHCl3) or iodoform (CHI3), has been banned or severely restricted because of their distinct toxicity. Yet CCl4 continues to provide an important service today as a model substance

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门